Longhorn Vaccines and Diagnostics to Present Data on Mycobacterium Tuberculosis Vaccine Candidate, LHNVD-301, at The Union World Conference on Lung Health 2023
BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Nov 2, 2023--<a ...
BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Nov 2, 2023--<a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 2, 2023--Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in the ...
MANASSAS, Va.--(BUSINESS WIRE)--Nov 2, 2023--<a ...
SAN FRANCISCO & COLUMBIA, Md.--(BUSINESS WIRE)--Nov 2, 2023--<a ...
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Nov 2, 2023--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( <em>Bicycle 庐</em> ) ...
TORONTO--(BUSINESS WIRE)--Nov 2, 2023--<a ...